Pacific Edge Buoyed by European Acceptance of Gastric Cancer Detection Patents

by Kathy Jones on  November 7, 2011 at 8:46 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

Patents for gastric cancer detection technology developed by biomedical company Pacific Edge have now been accepted in Europe, Australia and New Zealand, the company has announced.
 Pacific Edge Buoyed by European Acceptance of Gastric Cancer Detection Patents
Pacific Edge Buoyed by European Acceptance of Gastric Cancer Detection Patents

The company, which is based in Dunedin, New Zealand, already has technologies that are used for detecting bladder and colorectal cancer in the country.

Pacific Edge chief executive David Darling said that the company was hoping for wider acceptance of its patents in the coming 2 years, "These new technologies we are now commercializing enable early detection and better management of cancer and are expected to provide significant opportunities for the company, globally," he added.

Pacific Edge said that the fact that Europe has accepted its patents underline the strong science on which the company's cancer detection technologies are built.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Gastric Cancer Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...